Joyance Partners

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.

Mae is a women's health care center providing pregnancy and postpartum support, tailored to women's needs. Mae is establishing a world in which high-quality, proactive care is the norm. Mae improves the quality of care for Black women by providing a trusted, digital-first health platform.

Sunnyside develops an alcohol tracking app that helps individuals build healthier drinking habits. It creates personalized plans based on users' current habits and goals, setting daily reminders via text messages to limit alcohol intake.

Alba Health is a company focused on enhancing children's gut health through digital solutions and advanced microbiome testing. It offers an innovative stool test kit designed for easy use, allowing parents to analyze their child's gut microbiome in a certified laboratory. Upon completion of the analysis, detailed results are provided, which enable parents to collaborate with dieticians in formulating personalized action plans for their children's dietary and health needs. Additionally, Alba Health places significant emphasis on data privacy by anonymizing test results, which can contribute to broader discoveries that positively influence children's health outcomes. The company's overarching mission is to improve the health of future generations by leveraging artificial intelligence and microbiome science.

Nimble Science Ltd. is a digital health company focused on revolutionizing gastrointestinal (GI) health through its innovative SIMBA capsule technology. This end-to-end platform facilitates multi-omic mapping of the GI tract, allowing for the passive sampling of small bowel luminal fluid. By leveraging this advanced sampling method, Nimble Science provides precision datasets that offer valuable insights into GI health, thereby transforming the diagnosis and treatment of gastrointestinal conditions. The company's approach enables healthcare providers to directly sample and analyze targeted regions of the GI tract, marking a significant advancement in the understanding and management of GI health.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.

AOA, based in Boston, New York, and London, is a female-led company focused on developing innovative cancer diagnostics specifically for women's health. The company is dedicated to creating the first accurate early-stage liquid biopsy test for ovarian cancer, which aims to enhance clinical practices, reduce patient mortality, and offer cost savings for healthcare payers. Utilizing an artificial intelligence-enabled platform, AOA's technology analyzes tumor marker gangliosides to facilitate the early detection of ovarian cancer. This approach not only helps healthcare providers implement more effective treatment strategies but also ensures that patients can access life-saving treatments sooner and at a more affordable cost.

Ombre specializes in microbiome testing kits that offer personalized probiotics based on individual test results. Their subscription-based service provides actionable insights into gut health, aiming to prevent chronic diseases such as obesity, cystic fibrosis, and Alzheimer's.

IDUN Technologies designs and manufactures biosensors for wearable devices, specializing in dry conductive electrodes for bio-potential monitoring (ECG, EEG, EMG). Its innovative products enable convenient EEG monitoring suitable for consumer applications and brain-computer interfaces. Founded in 2017, the company is based in Opfikon, Switzerland.

Zone7 is a company that specializes in artificial intelligence-based software designed to predict sports injuries and optimize athletic performance. Founded in 2017 and headquartered in Palo Alto, California, Zone7 collects and analyzes data from various sources, including wearable devices, medical records, and fitness profiles. The software aims to identify injury risks before they occur, enabling coaching staff and medical professionals to make informed decisions regarding training, rest, and work assignments. Zone7's technology is utilized by over 30 professional sports franchises and is also applied in hospitals to monitor the well-being of medical staff. By providing actionable insights, Zone7 enhances the health, potential, and durability of athletes and the elite workforce, ultimately aiming to improve human performance across various fields.

Clay is an education company specializing in behavioral health solutions for early childhood education. It swiftly detects behavioral and developmental issues, advocates for improved outcomes, and supports preschools in managing disruptive behaviors and delays. Clay offers comprehensive mental health services to school communities, aiming to enhance children's and families' lives through early, integrated access to behavioral healthcare.

Dame Products is a sexual wellness brand dedicated to designing high-quality sex toys that enhance intimacy. The company prioritizes consumer needs, collaborating with women and sex therapists to create vibrators tailored to diverse sexual experiences.

Zone7 is a company that specializes in artificial intelligence-based software designed to predict sports injuries and optimize athletic performance. Founded in 2017 and headquartered in Palo Alto, California, Zone7 collects and analyzes data from various sources, including wearable devices, medical records, and fitness profiles. The software aims to identify injury risks before they occur, enabling coaching staff and medical professionals to make informed decisions regarding training, rest, and work assignments. Zone7's technology is utilized by over 30 professional sports franchises and is also applied in hospitals to monitor the well-being of medical staff. By providing actionable insights, Zone7 enhances the health, potential, and durability of athletes and the elite workforce, ultimately aiming to improve human performance across various fields.

Founded in Barcelona in 2017, Elma is a health technology company dedicated to improving care quality, affordability, and speed through its insurance business. It offers an e-healthcare application enabling doctor-patient communication via chat, calls, or video conferencing for personalized medical services.

InformAI provides artificial intelligence and analytics solutions for healthcare, enabling faster diagnoses, improved radiology productivity, and enhanced patient outcome analysis. The company develops AI-enabled tools for image classification in MRI and CT scans, natural language processing of medical reports for business analytics, and predictive models for patient outcomes and operational efficiency. Its software targets healthcare systems, imaging/PACS providers, medical device companies, and research institutes, supporting diagnostic decision-making, workflow optimization, and risk assessment across clinical care. Founded in 2017 and based in Houston, InformAI aims to synthesize large clinical datasets and deliver actionable insights to drive improved patient outcomes and operational performance.

Feebris Ltd is a UK-based company, founded in 2017 and headquartered in Saffron Walden, that specializes in developing artificial intelligence and machine learning algorithms for the detection of respiratory conditions. The company creates a mobile software platform that integrates with various point-of-care devices, such as digital stethoscopes and wearables. This technology is designed for community-based diagnosis and monitoring, allowing non-clinical users to identify early signs of deterioration in patients, thereby preventing complications and reducing the need for hospitalization. Feebris' team comprises experts in biomedical engineering, machine learning, global health, and business, all dedicated to transforming healthcare into a more equitable, personalized, and patient-driven system.

Folia Health, Inc. is a Cambridge-based company that has developed an innovative web application designed for family caregivers to document and manage the daily observations of patients, particularly those with chronic conditions. Founded in 2016, Folia Health's platform allows caregivers to record health outcomes and share this critical information with healthcare teams during appointments, facilitating improved patient care. The application captures unique health data that reflects the patient's overall experience with disease and treatment, empowering caregivers and enhancing the understanding of disease burden. By focusing on patient-driven care and leveraging longitudinal data, Folia Health aims to support precision diagnostics and foster patient-centered drug development, contributing to a more effective and holistic approach to healthcare.

Lazarus Enterprises Inc. is a company that develops and operates a clinical decision support platform aimed at improving cancer detection. Founded in 2017 and based in Cambridge, Massachusetts, Lazarus utilizes patient health data and artificial intelligence to enhance diagnostic accuracy for skin and cervical cancers. The platform provides automatic analysis of medical images and delivers instant results, ensuring seamless integration with electronic health records. By supporting healthcare professionals in early cancer detection, Lazarus aims to contribute to better patient outcomes and more effective treatment strategies.

AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.

Founded in Barcelona in 2017, Elma is a health technology company dedicated to improving care quality, affordability, and speed through its insurance business. It offers an e-healthcare application enabling doctor-patient communication via chat, calls, or video conferencing for personalized medical services.

Founded in London in 2017, Limbic specializes in developing software solutions for mental health. They create AI-driven agents to assist in patient intake, triage, screening, and therapy, aiming to enhance the efficiency of healthcare providers and improve patient outcomes.

FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

IrisVision specializes in digital vision technologies. It has developed the world's first smart visual assistive device using wearable VR technology, designed to help millions of visually impaired individuals regain sight, achieve independence, and enhance their daily lives.

Pnoe develops a metabolic analysis device that analyzes physiological data through breath analysis to deliver clinically accurate measurements of metabolic rate, cardiopulmonary function, and cellular fitness. The device enables health and fitness professionals to identify limiting factors and design science-based nutrition and training programs tailored to individual clients.

BrainKey is developing a digital therapeutics platform that analyzes vast amounts of brain data using AI-derived biomarkers. This enables more accurate diagnoses and personalized treatment recommendations for brain diseases, improving patient outcomes.

Singularity.AI offers an AI-driven platform for medical image and data analytics. It enables life sciences and healthcare professionals to derive insights from complex images and data, connect disparate datasets, collaborate across disciplines and institutions, thereby accelerating medical innovation while preserving data privacy.

ProbiusDx Inc. is a manufacturer of portable diagnostic devices that utilize an electronic sensing platform to analyze multiple target proteins in real time. Founded in 2015 and headquartered in El Cerrito, California, the company focuses on providing diagnostic technology for the detection and monitoring of blood concentrations. This innovative approach allows healthcare professionals to make informed decisions regarding appropriate therapies for patients in critical care settings. ProbiusDx aims to enhance patient outcomes through its advanced diagnostic solutions.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.

Solarea Bio is a biotechnology company that develops microbial therapeutics derived from healthy food sources. It uses computational approaches to create synergistic combinations of bacteria, fungi, and prebiotic fibers with anti-inflammatory properties, targeting chronic health conditions such as osteopenia and osteoporosis in postmenopausal women.

Ombre specializes in microbiome testing kits that offer personalized probiotics based on individual test results. Their subscription-based service provides actionable insights into gut health, aiming to prevent chronic diseases such as obesity, cystic fibrosis, and Alzheimer's.

Flux Biosciences is a company that originated from Stanford University, leveraging technology initially developed for reading and writing computer hard drives to create advanced point-of-care in vitro medical diagnostics. Its portable biosensor platform allows for the measurement of various biomarkers found in blood, urine, or saliva, providing insights related to exercise, stress, fertility, and diet. The biosensors are designed to detect specific biomarkers through real-time interactions with magnetic nanoparticles, enabling the simultaneous measurement of multiple markers from a single sample. By integrating data from these measurements with sleep and activity information from wearable devices, Flux Biosciences aims to empower individuals to manage their health and lifestyle choices more effectively, making medical-grade diagnostics accessible and actionable within the home.